NAN Fung Group Holdings LTD is based out of Central. Their last reported 13F filing for Q4 2023 included $160,556,343 in managed 13F securities
and a top 10 holdings concentration of 82.84%. NAN Fung Group Holdings LTD's largest holding is Karuna Therapeutics Inc with shares held of 225,688. Whalewisdom has at least 11 13F filings, and 6 13D filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
MIRM Mirum Pharmaceutical | 1.77% |
ALPN Alpine Immune Scienc | 1.44% |
PACB Pacific Biosciences | 0.75% |
KALV KalVista Pharmaceuti | 0.49% |
MDGL Madrigal Pharmaceuti | 0.17% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
SGEN Seagen Inc | 8.09% |
OCS Oculis Holding AG | 1.77% |
AKRO Akero Therapeutics I | 0.18% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
KRTX Karuna Therapeutics | 44.49% |
ILMN Illumina Inc | 10.34% |
HRMY Harmony Biosciences | 7.42% |
OCS Oculis Holding AG | 3.63% |
EXAI Exscientia Ltd | 3.43% |
2023-12-31
13F Activity
Market Value | $161m, Prior: $123m |
New Purchases | 2 stocks |
Added To | 4 stocks |
Sold out of | 2 stocks |
Reduced holdings in | 1 stocks |
Top 10 Holdings % | 82.84% |
Turnover %[1] | 10.26% |
Turnover Alt %[2] | 4.49% |
Time Held Top 20 | 5.75 quarters |
Time Held Top 10 | 4.9 quarters |
Time Held All | 6.85 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31